BioSpace News Archive

Pixium Vision Announces its 2017 Annual Results and Provides Business Update

Pixium Vision announced today its 2017 financial results.

February 8, 2018

·

9 min read

Business

pSivida Corp. Reports Second Quarter FY2018 Results; Continues to Achieve Milestones and Timelines

The company also provided an update on its continued operating progress.

February 8, 2018

·

10 min read

Policy

Curetis Unyvero HPN Receives Approval in Singapore

With this approval, Unyvero HPN is now fully registered as a Class C IVD medical device with the Singapore Medical Device Register.

February 8, 2018

·

3 min read

Business

Hologic Announces Financial Results for First Quarter of Fiscal 2018

Hologic announced today the Company’s financial results for the fiscal first quarter ended December 30, 2017.

February 8, 2018

·

71 min read

National Comprehensive Cancer Network adds Jazz Pharma’s Vyxeos Liposome for Injection to Clinical Practice Guidelines in Oncology

Vyxeos is the first FDA-approved treatment specifically for adults with newly-diagnosed Therapy-Related AML or AML with AML-MRC.

February 8, 2018

·

8 min read

Business

Acceleron Announces Appointment of Chief Commercial Officer

Acceleron today announced the appointment of commercial industry leader, Sujay Kango as Chief Commercial Officer (CCO).

February 8, 2018

·

3 min read

Business

Exelixis to Release Fourth Quarter and Full Year 2017 Financial Results on Monday, February 26, 2018

Exelixis management will host a conference call and webcast to discuss the results and provide a general business update.

February 8, 2018

·

2 min read

Drug Development

Amgen Release: Results From Phase III XGEVA (Denosumab) Study In Patients With Multiple Myeloma Published In The Lancet Oncology

In this study, XGEVA successfully met the primary endpoint, demonstrating non-inferiority to zoledronic acid in delaying the time to first on-study skeletal-related event in patients with multiple myeloma (HR=0.98, 95 percent CI: 0.85-1.14).

February 8, 2018

·

18 min read

Deals

Aviragen and Vaxart Amend Terms of Merger Agreement to Increase the Value for Aviragen Stockholders

Under the new terms, Aviragen stockholders would now own 49% of the combined company, up from 40% under the previous agreement.

February 8, 2018

·

9 min read

Business

OraSure Announces Record 2017 Fourth Quarter and Full-Year Financial Results

Consolidated net revenues for the fourth quarter of 2017 were $52.0 million, a 47% increase from the fourth quarter of 2016.

February 8, 2018

·

17 min read